Announcements Trials
Browse Landscape

Phase

Phase 2 9Phase 3 3Phase NA 2Phase 1/2 2Phase 1 1

Status

Completed 2Terminated 1

Sponsor Class

OTHER 2INDUSTRY 1

Study Type

Interventional 3

Sponsor

Cancer Type

Plasma cell 1CNS 1

Conditions

Fatigue 3Neoplasms 1Multiple Myeloma 1Brain Neoplasms 1

Interventions

Cisplatin 186Carboplatin 181Paclitaxel 175Docetaxel 144Cyclophosphamide 129Dexamethasone 117pembrolizumab 106Doxorubicin 103Bevacizumab 103Gemcitabine 102Rituximab 96Prednisone 87Fluorouracil 86Pemetrexed 81Radiotherapy 77Vincristine 71Etoposide 71Capecitabine 69Nivolumab 68Trastuzumab 67Leucovorin 64Cytarabine 57Methotrexate 52Oxaliplatin 49atezolizumab 47Lenalidomide 43Ipilimumab 40Filgrastim 40Bortezomib 39Sorafenib 38

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 3 × Has results × Modafinil × Clear all
NCT01781468 2025-01-27

Armodafinil in Reducing Cancer-Related Fatigue in Patients With High Grade Glioma

Alliance for Clinical Trials in Oncology

Phase 3 Completed
328 enrolled 15 charts

Fatigue

NCT00418691 2020-09-23

Effects of Methylphenidate Versus Sustained Release Methylphenidate on Cognitive Functioning

M.D. Anderson Cancer Center

Phase 3 Terminated
34 enrolled 7 charts
CNS

Brain Neoplasms, Fatigue

NCT01160380 2014-11-06

A Study of the Effectiveness of Armodafinil to Treat Cancer-Related Fatigue in Patients With Multiple Myeloma

Oncotherapeutics

Phase 3 Completed
50 enrolled 14 charts
Plasma cell

Fatigue, Multiple Myeloma, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡